Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 16Triple Negative Breast Neoplasms 5Stomach Neoplasms 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 4Neoplasms 3Neoplasm Metastasis 3Nasopharyngeal Carcinoma 3Adenocarcinoma 3Colorectal Neoplasms 2Biliary Tract Neoplasms 2Rectal Neoplasms 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Locally Advanced Gastric Cancer 1Glioblastoma 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1Childhood Solid Tumor 1Breast Neoplasm Malignant Female 1Brain Neoplasms 1Advanced Solid Tumour 1Advanced Rectal Cancer 1Adjuvant Drug Therapy 1

Interventions

irinotecan sucrosofate 1Folfox protocol 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Rectal Cancer × Capecitabine × 30 days × Clear all
NCT07281157 2026-06-03

Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡